0.96 USD
▼-0.10-9.07%
盘后 0.99 +2.71%
2026-11-20
市值
$8.12M
市盈率
—
EPS
-0.79
股息率
—
52 周区间
0.78 – 3.95
成交量
38.76K
Beta
0.79
目标价
22.00
52W 低 0.7852W 高 3.95
价格走势
公司简介
BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company’s pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applic...